Mostrar el registro sencillo del ítem

dc.contributor.authorGiacomazzi, Julianapt_BR
dc.contributor.authorZiegelmann, Patricia Klarmannpt_BR
dc.contributor.authorCosta, Samanta dapt_BR
dc.contributor.authorBittar, Camila Matzenbacherpt_BR
dc.contributor.authorObst, Fernando Marianopt_BR
dc.contributor.authorRosset, Cléviapt_BR
dc.contributor.authorMacedo, Gabriel Souzapt_BR
dc.contributor.authorBock, Hugopt_BR
dc.contributor.authorCanal, Thaispt_BR
dc.contributor.authorPaese, Mari Inespt_BR
dc.contributor.authorBenvenuti , Jean Lucaspt_BR
dc.contributor.authorBuj, Maria Carolinapt_BR
dc.contributor.authorProlla, Patrícia Ashtonpt_BR
dc.contributor.authorGoldim, José Robertopt_BR
dc.contributor.authorPozza, Robertapt_BR
dc.date.accessioned2025-09-10T07:55:54Zpt_BR
dc.date.issued2023pt_BR
dc.identifier.issn2687-8941pt_BR
dc.identifier.urihttp://hdl.handle.net/10183/296494pt_BR
dc.description.abstractPurpose: To evaluate cancer risk factors among cancer cases and controls from Southern Brazil, to analyze a multigene hereditary panel testing (MGPT, 26 genes) for breast cancer (BC) and colorectal cancer (CCR) cases diagnosed age younger than 50 years and to characterize them for hereditary cancer syndrome (HCS) phenotypes. Methods: A case-control (matched by age group and sex) study was conducted on regional cancer. Data on exposure factors and first-/second-degree family history of cancer (1/2FHC) were collected. The MGPT was performed using Illumina next-generation sequencing technology. Results: A total of 1,007 cases and 1,007 controls were included. The most frequent cancers were BC (n = 311), CCR (n = 147), prostate (n = 132), and lung cancers (n = 89). It was independently associated with cancer, 1/2FHC, tobacco consumption (TC), pesticide exposure (PE), solvent/glue exposure, and BMI <24. BC was associated with 1/2FHC, TC, and hormone replacement therapy use; CCR with 1/2FHC, TC, and BMI <24; prostate cancer with 1/2FHC, TC, and alcohol consumption; and lung cancer with 1/2FHC, TC, PE, and BMI <24. MGPT identified pathogenic/likely pathogenic mutations in 24 (32%) women with BC and in three (18%) women and four (24%) men diagnosed with CCR at under 50 years. Among the tested patients under 50 years with diagnosed BC and CCR, 98.6% and 97% present criteria for HCS, respectively. Conclusion: This study confirmed the association of several factors associated with BC, CCR, prostate, and lung cancers and reinforced the importance of evaluating FHC and genetic testing, especially for patients under 50 years with diagnosed BC or CCR. A better understanding of population-specific cancer risk factors builds on sustainable data for developing prevention strategies. These efforts increase the commitment to early detection and surveillance.en
dc.format.mimetypeapplication/pdfpt_BR
dc.language.isoengpt_BR
dc.relation.ispartofJCO Global Oncology. United States. Vol. 9 (Dec. 2023), e2300006, 17 p.pt_BR
dc.rightsOpen Accessen
dc.subjectFatores de riscopt_BR
dc.subjectCancer risk factorsen
dc.subjectHereditary cancer syndrome (HCS)en
dc.subjectCancer : Diagnostico precocept_BR
dc.subjectMultigene panel testing (MGPT)en
dc.subjectFamily history of canceren
dc.titleCancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Studypt_BR
dc.typeArtigo de periódicopt_BR
dc.identifier.nrb001292255pt_BR
dc.type.originEstrangeiropt_BR


Ficheros en el ítem

Thumbnail
   

Este ítem está licenciado en la Creative Commons License

Mostrar el registro sencillo del ítem